Ex-employees of Serum Inst booked for stealing vaccine info

Image
Press Trust of India Pune
Last Updated : May 08 2016 | 8:07 PM IST
Two former employees of the Serum Institute of India here have been booked for breach of trust for allegedly stealing confidential information about a vaccine before quitting the company, police said.
Police identified the accused as Dr Manoj Kumar Chhikara and Dr Rakesh Rana, who worked as assistant managers (R&D) and Quality Control, respectively.
No arrests have been made in case yet, they said.
The two are now working with Delhi-based MSD Wellcome Trust Hilleman Laboratories.
"Both of them were working on the vaccine called 'MenAfriVac', however, in 2011, Rana left the job and in 2013 Chhikara too resigned from the Serum Institute of India," inspector Anjum Bagwan of Hadapsar Police station said.
"The suspects, who were privy to the confidential details of vaccine, filed for patent on the basis of these details on behalf of their present employer and put their names as researchers in the patent application," Bagwan said.
When the Serum Institute officials filed an online patent application for their vaccine, they found another application with same specifications and names of these two scientists as researchers.
"When Chhikara and Rana were working on the project at Serum, they had signed a contract that they would not divulge information outside but they allegedly violated the term after leaving the Institute," the police officer said.
Police yesterday registered a case under IPC (Indian Penal Code) sections 420 (cheating), 406 (criminal breach of trust), and provisions of the Information Technology Act.
Serum Institute of India, which belongs to the Cyrus Poonawala Group, is a producer of diphtheria, tetanus, pertussis, BCG, r-hepatitis B, measles, mumps and rubella vaccines.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 08 2016 | 8:07 PM IST

Next Story